ADMA Biologics ADMA Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ADMA Biologics's total liabilities?
- ADMA Biologics (ADMA) reported total liabilities of $274.86M in Q1 2026.
- How has ADMA Biologics's total liabilities changed year-over-year?
- ADMA Biologics's total liabilities increased by 100.4% year-over-year, from $137.15M to $274.86M.
- What is the long-term trend for ADMA Biologics's total liabilities?
- Over 5 years (2020 to 2025), ADMA Biologics's total liabilities has grown at a 4.2% compound annual growth rate (CAGR), from $119.42M to $146.92M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.